Page 32 - Autumn 2018
P. 32
The Achievement of
one of the Members of
15 Pardis Technology Park
in reducing the severity of
diseases
The history of using amniotic recipient’s immune system
membrane in research and its graft (transplantation)
and treatment specifically is easily accepted. It provides
falls back to more than the tissues with a bio-barrier,
one hundred years ago. and it is processed based on
This biological substance, the international standards’
disposed as a bio-waste, instructions in a totally
has consolidated its role in sterile environment and in
restoration medicine. From cleanrooms.
among the characteristics This membrane has many
of amniotic membrane we usages. Treatment of chronic
can refer to being rich in and acute ulcers, eye and
growth factor, anti-microbial general surgeries, dentistry
properties, reduction of and chemical burns etc.
infections on the wound can all be carried out by
spot and anti-inflammatory this membrane. Sina Cell
properties in order to prevent Company, located in Pardis
the formation of eschar Technology Park, is the first
following the restoration of company holding an official
the wounds. In addition, the license for the production
anti-inflammatory property of of stem cells, cartilage
this dressing reduces the pain tissue engineering, amniotic
in the wound spot. Amniotic membrane and fibroblasts,
membrane creates a suitable and it is also the producer of
matrix for the migration and ALLO-STEMSIN and CELL-
proliferation of cells. This AMINIOSIN, which are useful
biological substance has a in treating diabetic foot ulcer,
32
PTPE-NEWSLET TER low level of immunization. bedsore, corneal surgery and
www.techpark.ir So, it is not rejected by the gum diseases etc.
